Globus Medical Inc-A 2026年季度报告

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934For the quarterly period ended March 31, 2026orTRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934For the transition period from ______________ to _______________ Commission File No. 001-35621 GLOBUS MEDICAL, INC.(Exact name of registrant as specified in its charter) 04-3744954 (I.R.S. Employer Identification No.) (610) 930-1800 (Registrant’s telephone number, including Area Code) Not Applicable (Former Address)Securities registered pursuant to Section 12(b) of the Act: Title of each classTrading SymbolsName of exchange on which registeredClass A Common Stock, par value $.001 per shareGMEDNew York Stock Exchange Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the SecuritiesExchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports),and (2) has been subject to such filing requirements for the past 90 days: YesNo Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submittedpursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that theregistrant was required to submit such files): YesNo Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smallerreporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smallerreporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act: Large AcceleratedFilerAccelerated FilerNon-accelerated FilerSmaller ReportingCompanyEmerging GrowthCompany If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period forcomplying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act): YesNo The number of shares outstanding of the issuer’s common stock (par value $0.001 per share) as of May5, 2026 was 135,744,626shares. GLOBUS MEDICAL, INC. AND SUBSIDIARIESTABLE OF CONTENTS PageCAUTIONARY NOTE CONCERNING FORWARD-LOOKING STATEMENTS3PART I.FINANCIAL INFORMATION4Item 1.Financial Statements4Condensed Consolidated Balance Sheets (Unaudited)March 31, 2026 and December 31, 20254Condensed Consolidated Statements of Operations and Comprehensive Income (Unaudited)Three months ended March 31, 2026 and March 31, 20255Condensed Consolidated Statements of Equity (Unaudited)Three months ended March 31, 2026 and March 31, 20256Condensed Consolidated Statements of Cash Flows (Unaudited)Three months ended March 31, 2026 and March 31, 20257Notes to Condensed Consolidated Financial Statements (Unaudited)8Item 2.Management’s Discussion and Analysis of Financial Condition and Results of Operations29Item 3.Quantitative and Qualitative Disclosures About Market Risk34Item 4.Controls and Procedures34PART II.OTHER INFORMATION36Item 1.Legal Proceedings36Item 1A.Risk Factors36Item 2.Unregistered Sales of Equity Securities and Use of Proceeds36Item 3.Defaults Upon Senior Securities36Item 4.Mine Safety Disclosures37Item 5.Other Information37Item 6.Exhibits37SIGNATURES38 Cautionary Note Concerning Forward-Looking Statements This Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of the Private SecuritiesLitigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of theExchange Act. All statements other than statements of historical fact are forward-looking statements. We have tried to identifyforward-looking statements by using words such as “believe,” “may,” “might,” “could,” “will,” “aim,” “estimate,” “continue,”“anticipate,” “intend,” “expect,” “plan” and similar words. These forward-looking statements are based on our current assumptions,expectations and estimates of future events and trends. Forward-looking statements are only predictions and are subject to many risks,uncertainties and other factors that may affect our businesses and operations and could cause actual results to differ materially fromthose predicted. These risks and uncertainties include, but are not limited to, the risks and costs associated with health epidemics,pandemics and similar outbreaks factors affecting our quarterly results, our ability to manage our growth, our ability to sustain ourprofitability, demand for our products, our ability to compete successfully (including without limitation our ability to convincesurgeons to use our products and our ability to attract and retain sales and other personnel), our ability to rapidly